CES 2026 / AI healthcare
At CES, Pixelro Proves Eye Health Self-Diagnosis Tech
Dong-A Ilbo |
Updated 2026.01.10
AI healthcare solutions company PIXELRO announced that its AI eye health self-diagnosis solution has been designated as an Innovation Product at CES 2026, the world’s largest technology industry exhibition.
At this year’s CES, PIXELRO showcased eye health self-diagnosis and self-testing solutions for older adults, centered on AI-based digital healthcare technology, and presented on the international stage the potential use of these solutions in public health management based on their regulatory approval as medical devices in the digital healthcare field.
The PIXELRO AI eye health self-diagnosis solution, designated as an Innovation Product, is characterized by providing non-face-to-face vision testing and eye health self-diagnosis. It enhances testing accuracy by applying real-time gaze tracking technology and left-right eye differentiation technology. The solution automatically calibrates the user’s testing environment and fixation status to deliver more reliable results. In addition, by linking vital measurement functions such as blood pressure and grip strength, it is designed to enable integrated management of eye health information and overall health indicators. Test results are stored and accessed on a cloud basis, facilitating not only the management of individual health records but also the use of data at the institutional level.
This solution is an approved medical device and serves both medical diagnostic purposes and as a public healthcare solution focused on health screening and prevention. It can be used for a wide range of public health management purposes, including health screening for residents at public health centers, schools, and public facilities, eye health management for older adults and students, and community-based preventive programs.
PIXELRO plans to simplify adoption procedures by public institutions through registration on the Innovation Marketplace and to contribute to the spread of a prevention-focused health management model based on digital healthcare.
A PIXELRO representative stated, “Through participation in CES 2026 and the designation as an Innovation Product, PIXELRO’s technological capabilities and public-sector application value have been recognized simultaneously,” adding, “We will continue to introduce solutions that create tangible social value in public healthcare and prevention-focused digital health management.”
At this year’s CES, PIXELRO showcased eye health self-diagnosis and self-testing solutions for older adults, centered on AI-based digital healthcare technology, and presented on the international stage the potential use of these solutions in public health management based on their regulatory approval as medical devices in the digital healthcare field.
The PIXELRO AI eye health self-diagnosis solution, designated as an Innovation Product, is characterized by providing non-face-to-face vision testing and eye health self-diagnosis. It enhances testing accuracy by applying real-time gaze tracking technology and left-right eye differentiation technology. The solution automatically calibrates the user’s testing environment and fixation status to deliver more reliable results. In addition, by linking vital measurement functions such as blood pressure and grip strength, it is designed to enable integrated management of eye health information and overall health indicators. Test results are stored and accessed on a cloud basis, facilitating not only the management of individual health records but also the use of data at the institutional level.
This solution is an approved medical device and serves both medical diagnostic purposes and as a public healthcare solution focused on health screening and prevention. It can be used for a wide range of public health management purposes, including health screening for residents at public health centers, schools, and public facilities, eye health management for older adults and students, and community-based preventive programs.
PIXELRO plans to simplify adoption procedures by public institutions through registration on the Innovation Marketplace and to contribute to the spread of a prevention-focused health management model based on digital healthcare.
A PIXELRO representative stated, “Through participation in CES 2026 and the designation as an Innovation Product, PIXELRO’s technological capabilities and public-sector application value have been recognized simultaneously,” adding, “We will continue to introduce solutions that create tangible social value in public healthcare and prevention-focused digital health management.”
Jung Jin-su
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.
Popular News
